These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment for periodic paralysis. Sansone V; Meola G; Links TP; Panzeri M; Rose MR Cochrane Database Syst Rev; 2008 Jan; (1):CD005045. PubMed ID: 18254068 [TBL] [Abstract][Full Text] [Related]
4. Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis. Tawil R; McDermott MP; Brown R; Shapiro BC; Ptacek LJ; McManis PG; Dalakas MC; Spector SA; Mendell JR; Hahn AF; Griggs RC Ann Neurol; 2000 Jan; 47(1):46-53. PubMed ID: 10632100 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Dichlorphenamide for Primary Periodic Paralysis in Adolescents Compared With Adults. Ciafaloni E; Cohen F; Griggs R Pediatr Neurol; 2019 Dec; 101():43-46. PubMed ID: 31570296 [TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of dichlorphenamide for treatment of primary periodic paralysis. Sansone VA; Johnson NE; Hanna MG; Ciafaloni E; Statland JM; Shieh PB; Cohen F; Griggs RC Muscle Nerve; 2021 Sep; 64(3):342-346. PubMed ID: 34129236 [TBL] [Abstract][Full Text] [Related]
7. Marked reduction in paralytic attacks in a patient with Andersen-Tawil syndrome switched from acetazolamide to dichlorphenamide. Gupta A; Iyadurai S; Roggenbuck J; LoRusso S Neuromuscul Disord; 2021 Jul; 31(7):656-659. PubMed ID: 34078557 [TBL] [Abstract][Full Text] [Related]
8. Dichlorphenamide (Keveyis) for periodic paralysis. Med Lett Drugs Ther; 2016 Apr; 58(1492):50. PubMed ID: 27049510 [No Abstract] [Full Text] [Related]
9. Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+ channels. Tricarico D; Mele A; Conte Camerino D Neuromuscul Disord; 2006 Jan; 16(1):39-45. PubMed ID: 16368240 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of familial hypokalemic paralysis with carbon dioxide anhydrase inhibitors]. Kold A Ugeskr Laeger; 1986 Jul; 148(28):1764-5. PubMed ID: 3750476 [No Abstract] [Full Text] [Related]
11. A newly approved drug for a rare group of diseases: Dichlorphenamide for periodic paralysis. Fontaine B; Phillips LH Neurology; 2016 Apr; 86(15):1366-1367. PubMed ID: 26865522 [No Abstract] [Full Text] [Related]
12. Treatment of "permanent" muscle weakness in familial Hypokalemic Periodic Paralysis. Dalakas MC; Engel WK Muscle Nerve; 1983; 6(3):182-6. PubMed ID: 6855804 [TBL] [Abstract][Full Text] [Related]
13. A rare case of unilateral adrenal hyperplasia accompanied by hypokalaemic periodic paralysis caused by a novel dominant mutation in CACNA1S: features and prognosis after adrenalectomy. Yang B; Yang Y; Tu W; Shen Y; Dong Q BMC Urol; 2014 Nov; 14():96. PubMed ID: 25430699 [TBL] [Abstract][Full Text] [Related]
14. Review of the Diagnosis and Treatment of Periodic Paralysis. Statland JM; Fontaine B; Hanna MG; Johnson NE; Kissel JT; Sansone VA; Shieh PB; Tawil RN; Trivedi J; Cannon SC; Griggs RC Muscle Nerve; 2018 Apr; 57(4):522-530. PubMed ID: 29125635 [TBL] [Abstract][Full Text] [Related]
15. Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol. Wang P; Clausen T Lancet; 1976 Jan; 1(7953):221-3. PubMed ID: 55532 [TBL] [Abstract][Full Text] [Related]
16. Open-Label, Dose-Escalation, Phase 1 Study of Safety and Single and Multiple-Dose Pharmacokinetics of Dichlorphenamide in Healthy Volunteers. Cohen F Clin Pharmacol Drug Dev; 2019 Jan; 8(1):87-94. PubMed ID: 29762909 [TBL] [Abstract][Full Text] [Related]
17. [From gene to diseases; hypokalemic periodic paralysis]. Links TP; Ginjaar HB; van der Hoeven JH Ned Tijdschr Geneeskd; 2004 May; 148(21):1035-8. PubMed ID: 15185439 [TBL] [Abstract][Full Text] [Related]
18. SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide. Venance SL; Jurkat-Rott K; Lehmann-Horn F; Tawil R Neurology; 2004 Nov; 63(10):1977. PubMed ID: 15557532 [No Abstract] [Full Text] [Related]